Clinical Trials Directory

Trials / Completed

CompletedNCT06413888

Nasogastric Decompression Following Pancreaticoduodenectomy

Routine Nasogastric Drainage vs. No Drainage Using Nasogastric Tube After Pancreaticoduodenectomy: A Randomized Control Trial [NCT ID Not Yet Assigned]

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
230 (actual)
Sponsor
Baylor College of Medicine · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Pancreaticoduodenectomy (PD) remains the gold-standard operation for peri-ampullary neoplasms. Traditionally, gastric decompression via nasogastric intubation has been employed postoperatively to prevent nausea, vomiting, aspiration pneumonia, anastomotic leakage and delayed gastric emptying. Recently, the implementation of ERAS protocol recommended against routine use of nasogastric tube following PD. however, limited data exists surrounding the identification of those patients needing NGT decompression in the immediate postoperative period. Therefore, we initiated a large prospective randomized controlled trial to evaluate the clinical outcomes of patients who retained the NGT post-PD versus those who had it removed at the end of the procedure. This study aims to assess the effectiveness of nasogastric decompression in PD recovery, with the primary endo point being the need for and impact of NGT in the postoperative recovery. The secondary endpoint will examined the re-insertion rate of NGT and identify factors that necessitate its use in the immediate postoperative period.

Conditions

Interventions

TypeNameDescription
PROCEDUREpancreaticoduodenectomySurgical removal of the head of the pancreas, duodenum, extrahepatic bile duct, distal stomach, and proximal jejunum. Group A cohort will not have NGT placed in the postoperative period. Whereas, group B will have the NGT retained in the posoperative period

Timeline

Start date
2018-06-01
Primary completion
2023-05-31
Completion
2023-12-31
First posted
2024-05-14
Last updated
2024-05-14

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT06413888. Inclusion in this directory is not an endorsement.